The aim of this study was to evaluate the possible relationship between several common genetic polymorphisms in DNA repair genes (ERCC1, ERCC2 and XRCC1) and the risk of developing RP in lung cancer patients receiving intensity modulation radiated therapy. The gene discussed is XRCC1; the disease is lung carcinoma.